Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 4,400 shares at $1.53 ($7K) on 2021-12-02, disclosed to the SEC on 2021-12-06.
Open-market purchase of $7k EMMA by Chairman and CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.53 | 3,400 | $5K | 77.0% |
| 2 | $1.55 | 1,000 | $2K | 23.0% |
| Total | $1.53 avg | 4,400 | $7K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |